Utah governor hopes to gain federal certification for the state's insurance exchange, which would ideally use a hybrid exchange model.
Utah Governor Gary Herbert has been in talks since December with the Department of Health and Human Services (HHS), hoping to gain federal certification for the state’s Avenue H insurance exchange, which launched in 2009. Herbert spoke with HHS Secretary Kathleen Sebelius last week to suggest a unique hybrid exchange model.
His suggestion is that the federal government would operate the state’s individual insurance exchange, the navigator program and the tax credit functions, while Utah would maintain Avenue H as a Small Business Health Options Program (SHOP) exchange. Herbert also wants Utah to retain control of Medicaid eligibility.
“We want to see if we cannot, in fact, coexist peacefully here and provide that to the marketplace,” he said during an American Enterprise Institute event. “Clearly there are still some details to work out.”
During talks, Sebelius seemed willing to “entertain the concept,” according to Herbert, and said she would like to “find a way to get to ‘yes.’”
The bifurcated exchange market could be more attractive to health plans. For example, James Murray, COO of Humana, recently told investors that the plan will determine its exchange participation market-by-market and state-by-state because it probably won’t be able to offer its HumanaOne product without also providing small-group coverage. Picking and choosing between individual and small-business markets could make certain exchanges more attractive than the exchanges that combine the markets.
Utah’s Avenue H currently serves 320 employers with more than 7,600 employees and dependents and offers only defined-contribution plans. Contributions vary from zero dollars to $2,000 per month with an average contribution of $437. Shoppers have 135 plan products to choose from. Exchange operations are overseen by a staff of five employees with a budget of $600,000, Herbert says.
He believes the exchange model is a fit for Utah where only 45% of businesses offer health benefits. Also, residents are younger with the average age of 29.2 years, he says. But the model wouldn’t necessarily be a fit for other states.
Herbert has long been a critic of the Patient Protection and Affordable Care Act that calls for exchanges with specific features in each state, and Utah was one of 26 states named as plaintiffs in the Supreme Court challenge against the law in 2012.
“We believe in the invisible hand of marketplace finding solutions rather than the heavy hand of government,” he says.
Moving forward on health reform, he says Utah will not: force the individual mandate even though the Supreme Court has ruled it constitutional; administer Medicaid through the exchange; or administer the premium tax credit through the exchange.
“We’re now to the point, like it or not, the Affordable Care Act is law of the land, and Utah is prepared to participate in that effort,” he says. “And we believe our exchange has a role to pay in the current situation.”
In this episode of the "Meet the Board" podcast series, Briana Contreras, Managed Healthcare Executive editor, speaks with Ateev Mehrotra, a member of the MHE editorial advisory board and a professor of healthcare policy and medicine at Harvard Medical School. Mehtrotra is also a hospitalist at the Beth Israel Deaconess Medical Center in Boston. In the discussion, Contreras gets to know Mehrotra more on a personal level and picks his brain on some of his research interests including telehealth, alternative payment models and price transparency.
Listen
Inflation Reduction Act: Reforms to Patient Cost-Sharing
September 18th 2023Lower out-of-pocket costs for patients might put upward pressure on drug prices, as manufacturers face less price sensitivity, note Matthew Majewski and Rhett Johnson of Charles River Associates. But they also note that upward pressure on price is likely to be limited to the inflation rate as any additional price increase would need to be paid back to CMS in the form of inflation rebates.
Read More
Spending climbed by 2.7% in 2021. In 2020, it soared by 10.3%, fueled by federal government spending in response to the pandemic. The blizzard of calculations of 2021 healthcare spending by CMS’ actuaries also provides further evidence that utilization of healthcare services bounced back in 2021.
Read More
Talking PIE, the Act, Before Thanksgiving
November 23rd 2022AMCP CEO Susan A. Cantrell spoke with Managed Healthcare Executive® about Preapproval Information Exchange (PIE) Act of 2022, which would allow drug manufacturers to share information about a drug with payers before the drug is approved. Cantrell says passage of the PIE Act would speed up patient access to new medications.
Read More
Inflation Reduction Act and the Impact on Pharmaceutical Pricing and Investment Decisions
November 21st 2022The reference to “maximum fair price” in the act bodes poorly for manufacturers and suggests more of a take-it-or-leave-it situation rather than a negotiation where clinical evidence would be the prevailing factor in determining price.
Read More